About Us
Who Are We
Rose Hill Life Sciences is a research-driven producer of Psilocybe cubensis biomass, extracts, and genetically characterized strains, operating at the intersection of natural product science and therapeutic innovation. With a focus on standardized cultivation, alkaloid profiling, and scalable biomass production, we support academic institutions, clinical researchers, and regulated therapeutic markets worldwide.
Our integrated supply chain—from spore to analytical data—ensures consistent, traceable inputs for psychedelic studies and product development. We engage in ethical and sustainable cultivation practices across diverse environments, including our flagship estate in Jamaica, while also collaborating with laboratories and universities to explore the full therapeutic potential of psilocybin.
Through strategic partnerships, R&D investment, and adherence to rigorous quality standards, Rose Hill Life Sciences is contributing to the scientific foundation needed to advance psilocybin-based therapies. Our work is guided by a commitment to integrity, evidence-based innovation, and global accessibility in mental health and neurological research.